NCT00003153View on ClinicalTrials.gov

Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 22, 1998

Primary Completion Date

February 28, 2007

Study Completion Date

May 1, 2009

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
BIOLOGICAL

therapeutic allogeneic lymphocytes

Trial Locations (2)

02215

Beth Israel Deaconess Medical Center, Boston

53226-3596

Medical College of Wisconsin Cancer Center, Milwaukee

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00003153 - Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation | Biotech Hunter | Biotech Hunter